Boston Scientific Corp (NYSE:BSX) is among the best medical AI stocks to buy now. Piper Sandler reaffirmed its Overweight ...

The device maker plans to invest 75 million euros into expanding the site, with a focus on cardiovascular innovation.

Boston Scientific Corporation (NYSE:BSX) is one of the most oversold healthcare stocks to invest in. Truist cut the price ...

The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.

Wall Street analysts forecast that Boston Scientific (BSX) will report quarterly earnings of $0.80 per share in its upcoming release, pointing to a year-over-year increase of 6.7%. It is anticipated ...

Boston Scientific (NYSE:BSX) today announced a €75 million (approximately $88.4 million) investment at its Galway, Ireland, ...

Boston Scientific Corporation BSX shares are down on Monday as the company faces pressure following a significant clinical ...

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.

TheFly reported on April 13 that Mizuho reduced its price target on BSX to $90 from $115 while maintaining an Outperform ...

Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the company's latest trial update.

The competition to be at the forefront of the pulsed field ablation market is undoubtedly fierce. Boston Scientific is vying to be the market leader in PFA, and a recent approval could help the ...

Medical device manufacturer Boston Scientific has announced a €75m investment in its Galway site, including the expansion of its research and development (R&D) capabilities.